Bull and Bear

Bull and Bear

Verdict: Lean Long, Wait For Confirmation - the recurring chronic-care growth and margin evidence outweigh the short case, but the cash-quality dispute keeps this from being a clean long call. The most important tension is whether cash generation is genuinely backing adjusted earnings or whether the new cash definition, receivables growth, and payable support are flattering the story. Bull wins on operating momentum: ex-InnovaMatrix growth held up, margin expansion has been delivered, and the stock is in a stressed technical setup despite a business that still compounds. Bear can still be right if FY2026 shows prior-definition equity cash conversion closer to the FY2025 bear baseline than to management's headline conversion. The conclusion changes if FY2026 ex-InnovaMatrix organic growth misses the 5-7% guide or if the old cash conversion reconciliation does not improve materially.

Bull Case

Bull's price target is $3.00 over 18 months. The method is a history-multiple case using 16.0x EV/EBITDA on FY2026 EBITDA, anchored to the Numbers $2.75 bull case on FY2025 data before FY2026 earnings growth. The timeline runs through the first FY2027 Accelerate evidence after FY2026 annual results, and the disconfirming signal is FY2026 organic growth excluding InnovaMatrix below 5.0%.

Bear Case

Bear's downside target is $1.92 per share over 12 months. The method is multiple compression to the Numbers bear case of 12.0x EV/EBITDA. The primary trigger is H1 2026 results on 4 August 2026 showing organic growth excluding InnovaMatrix below the 5-7% FY2026 guide path, and the cover signal is FY2026 prior-definition equity cash conversion above 90% with the old/new FCFE reconciliation still visible.

The Real Debate

Verdict

Verdict: Lean Long, Wait For Confirmation. Bull carries more weight because the operating facts are already observable: recurring revenue is high, ex-InnovaMatrix organic growth was 6.4% in FY2025, adjusted operating margin has moved from 17.7% to 22.3%, and FY2026 guidance requires another step to at least 23.0%. The single most important tension is cash conversion quality, because it decides whether margin expansion is turning into owner earnings or merely adjusted earnings. Bear could still be right if prior-definition cash conversion stays close to 61%, receivables keep outrunning revenue, or the old/new FCFE bridge disappears just as the market needs comparability. The condition that would change the verdict is a FY2026 miss on the 5-7% ex-InnovaMatrix organic growth guide or failure to show prior-definition equity cash conversion moving above 90%. Until that evidence arrives, the right conclusion is constructive but conditional rather than a full-throated long verdict.